 BioSig Technologies, Inc. NASDAQ:BSGM said it has entered into an evaluation agreement for its PURE EP System with Cleveland Clinic, its first following the induction of a new commercialization team to accelerate the process from product evaluation to adoption. The medical technology company said Cleveland Clinic, a non-profit multi-specialty academic medical center, will participate in a 60-day evaluation of BioSigs signal processing platform. 